Pediatric Cardiology focuses on diagnosing, treating and preventing congenital and acquired cardiovascular diseases in infants, children and adolescents. This field requires specialised expertise because pediatric patients often present with unique anatomical variations, age-dependent physiological responses and developmental considerations that differ significantly from adult cardiology. Families and clinicians increasingly look for advanced learning resources, evidence-based updates and detailed guidance through expert-led cardiology conference sessions that explore evolving diagnostic tools, interventional approaches and long-term management strategies for childhood heart diseases. As preventive care, early detection and genetic evaluation continue to expand, understanding the diverse landscape of pediatric cardiac disorders becomes even more essential for comprehensive care delivery.

This session examines congenital heart defects ranging from simple septal abnormalities to complex single-ventricle physiology. Clinicians learn updated methods for recognising murmurs, cyanosis, exercise intolerance, arrhythmias and heart failure symptoms in newborns and children. Because pediatric cardiovascular disease frequently intersects with congenital heart disease, discussions focus on detecting structural abnormalities through echocardiography, Doppler imaging, CT angiography and cardiac MRI. Participants will also explore fetal cardiology considerations, including prenatal diagnosis and perinatal planning for high-risk newborns.

Hemodynamic assessment plays a central role in pediatric cardiology, guiding decisions regarding catheterisation, interventional procedures, surgery and medical therapy. This session highlights pressure–volume relationships, shunt calculations, pulmonary vascular resistance and ventricular interactions. Attendees gain insight into how growth patterns and metabolic status influence cardiac function and treatment outcomes.

Treatment strategies vary widely depending on the underlying condition. Some children require pharmacological therapy including diuretics, ACE inhibitors, beta-blockers or pulmonary vasodilators, while others require catheter-based interventions such as ASD and PDA closures, balloon valvuloplasty or stent placement. For complex congenital lesions, surgical options such as the Fontan procedure, arterial switch or tetralogy repairs are covered extensively with emphasis on long-term surveillance and outcomes.

The session also highlights arrhythmias in children, including supraventricular tachycardia, junctional rhythms and inherited channelopathies. Clinicians learn to interpret pediatric ECGs, recognise red-flag symptoms and plan electrophysiological evaluations. Genetic testing is increasingly crucial for identifying syndromic associations, predicting risks and guiding family screening.

Long-term care focuses on neurodevelopmental outcomes, exercise guidance, endocarditis prevention and transition planning into adult congenital cardiology programmes. Participants will also explore psychological support, lifestyle counselling and strategies to improve adherence in adolescent patients.

Future directions include stem-cell based therapies, advanced imaging protocols, AI-assisted diagnostic models and evolving interventional devices designed specifically for small anatomies. This session provides clinicians with the foundation needed to deliver high-quality, coordinated care for diverse pediatric cardiac conditions.